Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trialHiddo J.L. Heerspink, Toby Coates, Stewart Bieler et al.|The Lancet|2023Cited by 214
Omacor(R), n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animalsHo Jun Chin, Dong‐Wan Chae|Nephrology Dialysis Transplantation|2009Cited by 30